Diana Abbott1, Nicholas E Johnson2, Lisa A Cannon-Albright3,4. 1. Division of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA. diana.abbott@utah.edu. 2. Department of Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA. 3. Division of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA. 4. George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah.
Abstract
INTRODUCTION: The risk of cancer in patients diagnosed with myotonic dystrophy (DM) is reported for the homogeneous Utah population. METHODS: Clinical data accessed from the largest Utah healthcare providers have been record-linked to the Utah Population Database, a population-based resource also linked to the Utah Cancer Registry. Relative risks were estimated for 36 cancers of different types in 281 DM patients. RESULTS: Testicular cancer (relative risk [RR] = 10.74; 95% confidence interval [CI], 1.91-38.79), endometrial cancer (RR = 6.98; 95% CI, 1.24-25.22), and non-Hodgkin lymphoma (RR = 4.25; 95% CI, 1.16-12.43) were all observed at significant excess in DM patients. CONCLUSIONS: This study confirms an overall increased risk of cancer in DM. Individuals diagnosed with DM might benefit from risk counseling. Muscle Nerve 54: 783-785, 2016.
INTRODUCTION: The risk of cancer in patients diagnosed with myotonic dystrophy (DM) is reported for the homogeneous Utah population. METHODS: Clinical data accessed from the largest Utah healthcare providers have been record-linked to the Utah Population Database, a population-based resource also linked to the Utah Cancer Registry. Relative risks were estimated for 36 cancers of different types in 281 DMpatients. RESULTS:Testicular cancer (relative risk [RR] = 10.74; 95% confidence interval [CI], 1.91-38.79), endometrial cancer (RR = 6.98; 95% CI, 1.24-25.22), and non-Hodgkin lymphoma (RR = 4.25; 95% CI, 1.16-12.43) were all observed at significant excess in DMpatients. CONCLUSIONS: This study confirms an overall increased risk of cancer in DM. Individuals diagnosed with DM might benefit from risk counseling. Muscle Nerve 54: 783-785, 2016.
Authors: Shahinaz M Gadalla; Marie Lund; Ruth M Pfeiffer; Sanne Gørtz; Christine M Mueller; Richard T Moxley; Sigurdur Y Kristinsson; Magnus Björkholm; Fatma M Shebl; James E Hilbert; Ola Landgren; Jan Wohlfahrt; Mads Melbye; Mark H Greene Journal: JAMA Date: 2011-12-14 Impact factor: 56.272
Authors: M Kinoshita; A Igarashi; T Komori; H Tamura; M Hayashi; K Kinoshita; T Deguchi; K Hirose Journal: Muscle Nerve Date: 1997-05 Impact factor: 3.217
Authors: Aung Ko Win; Promilla G Perattur; Jose S Pulido; Christine M Pulido; Noralane M Lindor Journal: Mayo Clin Proc Date: 2012-01-10 Impact factor: 7.616
Authors: Christine M Mueller; James E Hilbert; William Martens; Charles A Thornton; Richard T Moxley; Mark H Greene Journal: Cancer Causes Control Date: 2009-12 Impact factor: 2.506
Authors: M Lund; L J Diaz; S Gørtz; B Feenstra; M Duno; I Juncker; H Eiberg; J Vissing; J Wohlfahrt; M Melbye Journal: Eur J Neurol Date: 2014-05-17 Impact factor: 6.089
Authors: Shahinaz M Gadalla; Ruth M Pfeiffer; Sigurdur Y Kristinsson; Magnus Björkholm; James E Hilbert; Richard T Moxley; Ola Landgren; Mark H Greene Journal: PLoS One Date: 2013-11-13 Impact factor: 3.240
Authors: Jose I Emparanza; Adolfo López de Munain; Mark H Greene; Ander Matheu; Roberto Fernández-Torrón; Shahinaz M Gadalla Journal: Muscle Nerve Date: 2018-10 Impact factor: 3.217
Authors: Lauren A Dalvin; Carol L Shields; Jose S Pulido; Kareem Sioufi; Victoria Cohen; Jerry A Shields Journal: JAMA Ophthalmol Date: 2018-05-01 Impact factor: 7.389
Authors: A F Best; J E Hilbert; L Wood; W B Martens; N Nikolenko; C Marini-Bettolo; H Lochmüller; P S Rosenberg; R T Moxley; M H Greene; S M Gadalla Journal: Eur J Neurol Date: 2018-09-16 Impact factor: 6.089
Authors: Rotana Alsaggaf; Diane Marie M St George; Min Zhan; Ruth M Pfeiffer; Youjin Wang; Kathryn R Wagner; Mark H Greene; Sania Amr; Shahinaz M Gadalla Journal: JNCI Cancer Spectr Date: 2018-12-10
Authors: Rotana Alsaggaf; Diane Marie M St George; Min Zhan; Ruth M Pfeiffer; Youjin Wang; Lesley A Anderson; Zhiwei Liu; Jill Koshiol; Andrew J Bauer; Kathryn R Wagner; Mark H Greene; Sania Amr; Shahinaz M Gadalla Journal: Ann Clin Transl Neurol Date: 2019-07-26 Impact factor: 4.511
Authors: Rotana Alsaggaf; Ruth M Pfeiffer; Youjin Wang; Diane Marie M St George; Min Zhan; Kathryn R Wagner; Sania Amr; Mark H Greene; Shahinaz M Gadalla Journal: Int J Cancer Date: 2019-12-19 Impact factor: 7.316